Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SPIRIT I: Targretin + Chemo in NSCLC
NCT00050973Phase 3Completed
- Sponsor
- Eisai Co., Ltd.
- Primary completion
- Nov 2004
- Modality
- Orthosteric Ligands
- Countries
- 11
01
Overview
A Phase 3 trial of bexarotene in non-small cell lung cancer (NSCLC), sponsored by Eisai Co., Ltd.. Status: completed.
02
Drugs
bexarotene
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00050973.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00050973.